Delivery Order SPE2DB20D1100-SPE2DB25FC8C5
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Jolessa 0.15 mg-0.03 mg tablets, a pharmaceutical product, with a ceiling value of $1,178.45 and a performance period ending on June 26, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,104.25 firm-fixed-price contract is for the supply of Jolessa 0.15 mg-0.03 mg tablets. The contract has an ultimate completion date of April 17, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,539.51, is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of October 27, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product, with a ceiling value of $1,035.84 and a performance period ending on May 28, 2025. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product, with a ceiling value of $1,853.46 and a period of performance through March 12, 2024. The award is associated with a larger indefinite delivery contract (IDC) held by...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jolessa 0.15 mg-0.03 mg tablets. The $1,109.49 firm fixed-price contract has an ultimate completion date of October 8, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the prime contractor, for the delivery of Jolessa 0.15 mg-0.03 mg tablets. The contract is a firm fixed price delivery order with a ceiling value of $1,019.54 and a performance period through March 25, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, is providing these pharmaceutical products to support military...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG tablets, a pharmaceutical product, with a ceiling value of $2,500.51 and a completion date of September 25, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant...
This federal contract award, valued at $1,136.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a medical product, and has an ultimate completion date of December 10, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This federal contract award is for a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a prescription medication, with a ceiling value of $1,178.12 and a period of performance through May 8, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business category. Amerisourcebergen...